Whether it's uveitis, post‑surgery inflammation, or allergic conjunctivitis, anti‑inflammatory drugs are the go‑to. The ophthalmic drugs market research shows that anti‑inflammatories hold the largest share, driven by corticosteroid eye drops (prednisolone, dexamethasone) and NSAIDs (ketorolac, bromfenac). They're cheap, effective, and widely available. But long‑term steroid use can...

Pain is the most common reason people take medication. And oral thin films are perfect for acute pain — they work fast, no water needed. The oral thin film drugs market research shows that pain management is the largest application, with a projected value of $2.76 billion by 2035. Drugs like Suboxone (for opioid dependence) and fentanyl films (for breakthrough cancer pain) are...

According to a new report from Intel Market Research, the global Surgical Cap Making Machine market was valued at USD 78.5 million in 2025 and is projected to reach USD 125.7 million by 2034, growing at a CAGR of 5.1% during the forecast period (2026–2034). This growth is propelled by increasing surgical procedure volumes globally, heightened infection control awareness post-pandemic,...

Global Permethrin Cream Market continues to demonstrate steady growth, with its valuation reaching USD 8.90 million in 2023. According to the latest industry analysis, the market is projected to grow at a CAGR of 3.60%, reaching approximately USD 12.24 million by 2032. This growth is largely driven by rising instances of parasitic infections like scabies and lice, particularly in regions with...

For too long, chronic pain patients have been told their symptoms are exaggerated, psychological, or simply untreatable beyond a point. The medical community has been slow — sometimes painfully slow — to catch up with the lived reality of people dealing with conditions like fibromyalgia, complex regional pain syndrome, and persistent lower back pain. But something has genuinely...

There's a quiet revolution happening inside pharmaceutical manufacturing facilities around the world, and most people have absolutely no idea it's going on. As drugs become more complex — as we move from simple chemical compounds to living cell therapies, viral vectors, and protein-based biologics — the challenge of ensuring consistent quality becomes exponentially harder. And yet...

The COVID-19 pandemic was a stress test for global healthcare infrastructure, and in many ways it exposed just how dependent that infrastructure was on centralised laboratory testing. In the early months of the pandemic, the bottlenecks were painful and sometimes deadly — limited testing capacity, long turnaround times, overwhelmed labs. The pivot to rapid, decentralised point of care...

When pills don't work, or cause too many side effects, interventional procedures can be a game‑changer. Think: an epidural steroid injection for sciatica, or a spinal cord stimulator for failed back surgery syndrome. The pain management market research shows that interventional procedures are the fastest‑growing treatment type, with a CAGR above 7%. Why? Because they target the...